Publication: Ataluren metabolism: Ataluren-O-1β-acyl glucuronide is a stable circulating metabolite in mice, rats, dog and human
This research article, published in Drug Metabolism and Pharmacokinetics, evaluates the in vitro and in vivostabilityof ataluren-O-1β-acyl glucuronide metabolite
The safety profile of ataluren acyl glucuronide is presented
The in vitro and in vivo stability of ataluren acyl glucuronide in mice, rat, dog and human patients is discussed
Safety outcomes relating to ataluren-O-1β-acyl glucuronide are presented
Once registered, you will be able to view the abstract and be provided the DOI and PubMed links for this publication.
Ma J, Risher N, Northcutt V, et al. Drug Metab Pharmacokinet. 2021;38:100393
▼ Ataluren is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system. Adverse events should also be reported to PTC at email@example.com.
Registration conditions differ internationally, and prescribing information may vary depending on local approval in each country. The European Summary of Product Characteristics for ataluren is available here. Please refer to your local country guidance for more information.
Register now to unlock the content
Register now to access the content on this page
If not, register below
GL-DMD-0442 | October 2021
Sign in or register to access exclusive content on this site